Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry D Morgan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
2-Phenylspiroindenes: a novel class of selective estrogen receptor modulators (SERMs)Timothy A Blizzard, Jerry D Morgan, Ralph T Mosley, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Antibacterial activity of G6-quaternary ammonium derivatives of a lipophilic vancomycin analogueTimothy A Blizzard, Ronald M Kim, Jerry D Morgan, et al.
Journal of Diabetes and Its Complications|November 3, 2012
Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetesVivian Fonseca, Bart Staels, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Estrogen receptor ligands. Part 14: application of novel antagonist side chains to existing platformsTimothy A Blizzard, Jerry D Morgan, Wanda Chan, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2007
Androstene-3,5-dienes as ER-beta selective SERMsTimothy A Blizzard, Candido Gude, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2005
Androstenediol analogs as ER-beta-selective SERMsTimothy A Blizzard, Candido Gude, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chainsTimothy A Blizzard, Frank DiNinno, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chainsTimothy A Blizzard, Frank DiNinno, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkersTimothy A Blizzard, Frank Dininno, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMsQiang Tan, Timothy A Blizzard, Jerry D Morgan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
2-Phenylspiroindenes: a novel class of selective estrogen receptor modulators (SERMs)Timothy A Blizzard, Jerry D Morgan, Ralph T Mosley, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Antibacterial activity of G6-quaternary ammonium derivatives of a lipophilic vancomycin analogueTimothy A Blizzard, Ronald M Kim, Jerry D Morgan, et al.
Journal of Diabetes and Its Complications|November 3, 2012
Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetesVivian Fonseca, Bart Staels, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Estrogen receptor ligands. Part 14: application of novel antagonist side chains to existing platformsTimothy A Blizzard, Jerry D Morgan, Wanda Chan, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2007
Androstene-3,5-dienes as ER-beta selective SERMsTimothy A Blizzard, Candido Gude, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2005
Androstenediol analogs as ER-beta-selective SERMsTimothy A Blizzard, Candido Gude, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chainsTimothy A Blizzard, Frank DiNinno, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chainsTimothy A Blizzard, Frank DiNinno, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkersTimothy A Blizzard, Frank Dininno, Jerry D Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMsQiang Tan, Timothy A Blizzard, Jerry D Morgan, et al.
Pageof 1